2024 ISV ANNUAL CONGRESS
SEOUL, SOUTH KOREA
Dragon City Hotel
21 – 23 October 2024
Dear ISV Members, Colleagues, and Friends,
We are thrilled to announce that the International Society for Vaccines (ISV) Annual Congress returns to Asia, October 21-23, 2024 at the Dragon City Hotel, Seoul, Korea. The International Vaccine Institute (IVI), established by the United Nations Development Programme is partnering with ISV for this important event.
The 2024 ISV Annual Congress welcomes vaccinologists from all disciplines of human and veterinary prophylactic and therapeutic vaccination and immunotherapy. Participants come from every discipline, including basic research, development, regulatory issues, manufacturing, and epidemiology and from all sectors, whether academic, industrial, governmental or non-governmental institutions.
2024 Congress Chairs
Joon Haeng Rhee
Chonnam National University Medical School, South Korea
Margaret Liu
ProTherImmune, USA
Karolinska Institutet, Sweden
Shan Lu
UMASS Chan Medical School, USA
Ken Ishii
University of Tokyo, Japan
Jerome Kim
IVI – South Korea
Invited Speakers
(more to be added)
Alejandra Capozzo
UAI, Argentina
Nam-Hyuk Cho
Seoul National University, Korea
Brittany L. Hartwell
University of Minnesota, USA
Joseph Jardine
Scripps Research Institute, USA
Ijoo Kwon
GeneOne, Korea
Andreas Holm Mattsson
Evaxion, Denmark
Hong Jin
CyanVac LLC
Peter Lawaetz Andersen
Novo Nordisk Foundation, Denmark
Guanghui Ma
Chinese Academy of Sciences, China
Shabir A. Madhi
University of Witwatersrand, S. Africa
Ziad Memish
Riyadh, Saudi Arabia Ministry of Health
Dal-Hee Min
Lemonex/SNU, Korea
Nina Russell
Bill & Melinda Gates Foundation, USA
Yoshimasa Takahashi
National Institute of Infectious Diseases, Japan
Axel Timmermann
Pusan University, Austria
Birgit Weinberger
University of Innsbruck, Austria
2024 Scientific Committee
– CO-CHAIRS-
David Weiner, The Wistar Institute – USA
Alexander Bukreyev, University of Texas Medical Branch – USA
Kimberly Matheson, Sanofi Canada – Canada
Pervin Anklesaria, Bill & Melinda Gates Foundation – USA
Jason McLellan, University of Texas, Austin – USA
Neil Almond, MHRA – UK
Jacqueline Miller, Moderna – USA
Annaliesa Anderson, Pfizer – USA
Peter Openshaw, Imperial College – London
Danilo Casimiro, Aeras – USA
Clarisa, Palatnik de Sousa, Federal University of Rio de Janeiro – Brazil
Hualan Chen, National Avian Influenza Reference Laboratory – China
Sanjay Phogat, GSK – Italy
Zhiwei Chen, Hong Kong University – China
Punnee Pitisuttithum, Mahidol University-Thailand
Andrew Pollard, Jenner Institute and University of Oxford – UK
Mark Connors, NIH – USA
Gi-eun Rhie, Vaccine Research Center KDCA/KNIH – South Korea
David Salisbury, UK Department of Health (and WHO) – UK
Maria Elena Botazzi, Baylor – USA
Ann Ginsberg, Bill & Melinda Gates Foundation – USA
Manki Song, IVI – South Korea
Hoon Kim, SK bioscience – South Korea
Frederic Tangy, Institut Pasteur – France
Baik Lin Seong, University – South Korea
Petro Terblanche, Afrigen Biologics & Vaccines – South Africa
Anna Lise, Williamson, University of Cape Town – South Africa
Karin Loré, Karolinska Institutet – Sweden
Kapil Maithal, Vaccine Technology Centre – India